 August 4, 2020 Breda, the Netherlands Ghent, Belgium argenx Euronext Nasdaq: ARGX, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that Tim Van Hauwermeiren, Chief Executive Officer, will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Tuesday, August 11, 2020 at 12:35 p.m. ET.A live webcast of the presentation will be available on the Companys website at A replay of the webcast will be available for 90 days following the presentation.About argenx argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program IIP, argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx is evaluating efgartigimod in multiple serious autoimmune diseases, and cusatuzumab in hematological cancers in collaboration with Janssen. argenx is also advancing several earlier stage experimental medicines within its therapeutic franchises. argenx has offices in Belgium, the United States and Japan. For more information, visit and follow us on LinkedIn at For further information, please contact: Beth DelGiacco, Vice President, Investor Relations US 1 518 424 4980 Joke Comijn, Director Corporate Communications Investor Relations EU 32 0477 77 29 44 32 09 310 34 19 